Zdrowie i gospodarka · 23/09/2024

FDA Requests Public Comment on Proposed Adverse Experience Reporting

The Food and Drug Administration (FDA) is seeking public input on its proposed collection of postmarketing adverse experience data for pharmaceutical and biological products, as required by the Paperwork Reduction Act of 1995.